One concern regarding type 1 AIP/IgG4-RD patients exhibiting elevated IL-6 levels might be the simultaneous occurrence of type 1 AIP/IgG4-RD and MCD. Here, IL6 is linked to immunoglobulin G4-related sclerosing disease.